Furthermore, these findings enrich the comprehension of cancer biology and establish a foundation for advancing innovative therapeutic strategies that capitalize on the metabolic susceptibilities of malignant cells by investigating the functions of IFN-γ, STAT3, and c-Myc in facilitating this reprogramming process. The gene discussed is MYC; the disease is cancer.